Article (Scientific journals)
Structural and Kinetic Insights into the "Ceftazidimase" Behavior of the Extended-Spectrum beta-Lactamase CTX-M-96.
Ghiglione, Barbara; Rodriguez, Maria Margarita; Herman, Raphaël et al.
2015In Biochemistry, 54 (32), p. 5072-82
Peer Reviewed verified by ORBi
 

Files


Full Text
Ghiglione_2015.pdf
Publisher postprint (4.38 MB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Abstract :
[en] Diversification of the CTX-M beta-lactamases led to the emergence of variants responsible for decreased susceptibility to ceftazidime, like the Asp240Gly-harboring "ceftazidimases". We solved the crystallographic structure of the Asp240Gly variant CTX-M-96 at 1.2 A and evaluated the role of Asp240 in the activity toward oxyimino-cephalosporins through simulated models and kinetics. There seem to be subtle changes in the conformation of the active site cavity of CTX-M-96, compared to enzyme variants harboring the Asp240, and these small rearrangements could be due to localized shifts in the environment of the beta3 strand. According to the crystallographic evidence, CTX-M-96 presents a "compact" active site, which in spite of its reduced cavity seems to allow the proper interaction with oxyimino-cephalosporins, as suggested by simulated models. The term "ceftazidimases" that is currently applied for the Asp240Gly-harboring CTX-M variants should be used carefully. Structural differences between CTX-M harboring the Asp240Gly mutation (and also probably others like those at Pro167) do not seem to be conclusive to determine the "ceftazidimase" behavior observed in vivo, which is in turn partially supported by the mild improvement in the catalytic efficiency toward ceftazidime by CTX-M-96 and similar enzymes, compared to "parental" Asp240-harboring variants. In addition, it is observed that alterations in OmpF expression could act synergistically with CTX-M-96 for yielding clinical resistance toward ceftazidime. We therefore propose that the observed resistance in vivo is due to the sum of synergic mechanisms, and the term "cefotaximases associated with ceftazidime resistance" could be conveniently used to describe CTX-M harboring the Asp240Gly substitution.
Research center :
d‐BRU - Dental Biomaterials Research Unit - ULiège [BE]
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Ghiglione, Barbara
Rodriguez, Maria Margarita
Herman, Raphaël ;  Université de Liège > Département des sciences de la vie > Centre d'ingénierie des protéines
Curto, Lucrecia
Dropa, Milena
Bouillenne, Fabrice ;  Université de Liège > Département des sciences de la vie > Centre d'ingénierie des protéines
Kerff, Frédéric  ;  Université de Liège > Département des sciences de la vie > Centre d'ingénierie des protéines
Galleni, Moreno ;  Université de Liège - ULiège
Charlier, Paulette ;  Université de Liège > Département des sciences de la vie > Cristallographie des macromolécules biologiques
Gutkind, Gabriel
Sauvage, Eric ;  Université de Liège > Département des sciences de la vie > Centre d'ingénierie des protéines
Power, Pablo
Language :
English
Title :
Structural and Kinetic Insights into the "Ceftazidimase" Behavior of the Extended-Spectrum beta-Lactamase CTX-M-96.
Publication date :
2015
Journal title :
Biochemistry
ISSN :
0006-2960
eISSN :
1520-4995
Publisher :
American Chemical Society, Washington, United States - District of Columbia
Volume :
54
Issue :
32
Pages :
5072-82
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 23 November 2015

Statistics


Number of views
77 (13 by ULiège)
Number of downloads
0 (0 by ULiège)

Scopus citations®
 
10
Scopus citations®
without self-citations
6
OpenCitations
 
6

Bibliography


Similar publications



Contact ORBi